Medtronic submits full data on spinal protein to independent scrutiny.
作者信息
Cohen Deborah
出版信息
BMJ. 2011 Aug 30;343:d5484. doi: 10.1136/bmj.d5484.
PMID:21878463
Abstract
摘要
相似文献
1
Medtronic submits full data on spinal protein to independent scrutiny.
BMJ. 2011 Aug 30;343:d5484. doi: 10.1136/bmj.d5484.
2
[Too good to be true].
Tidsskr Nor Laegeforen. 2011 Nov 15;131(22):2228-9. doi: 10.4045/tidsskr.11.0841.
3
Exposing conflicts of interest and complications of rhBMP-2.
Neurosurgery. 2011 Oct;69(4):N21-2. doi: 10.1227/01.neu.0000405599.24202.aa.
4
Closing in on the truth about recombinant human bone morphogenetic protein-2: evidence synthesis, data sharing, peer review, and reproducible research.
Ann Intern Med. 2013 Jun 18;158(12):916-8. doi: 10.7326/0003-4819-158-12-201306180-00012.
5
A biologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research.
Spine J. 2012 Oct;12(10):877-80. doi: 10.1016/j.spinee.2012.11.002.
6
Folly of FDA-approval studies for bone morphogenetic protein.
Spine J. 2011 Jun;11(6):495-9. doi: 10.1016/j.spinee.2011.05.009.
7
Meta-analysis of trials of recombinant human bone morphogenetic protein-2: what should spine surgeons and their patients do with this information?
Ann Intern Med. 2013 Jun 18;158(12):912-3. doi: 10.7326/0003-4819-158-12-201306180-00010.
8
A historic moment for open science: the Yale University Open Data Access project and medtronic.
Ann Intern Med. 2013 Jun 18;158(12):910-1. doi: 10.7326/0003-4819-158-12-201306180-00009.
9
The changing structure of industry-sponsored clinical research: pioneering data sharing and transparency.
Ann Intern Med. 2013 Jun 18;158(12):914-5. doi: 10.7326/0003-4819-158-12-201306180-00011.
10
Resetting standards for sponsored research: do conflicts influence results?
Spine J. 2011 Jun;11(6):492-4. doi: 10.1016/j.spinee.2011.05.001.
Zotero 插件